Coronavirus: US vaccine candidate does well in experiment targeting common mutation

A vaccine candidate developed by scientists in the United States performed well in an experiment that pitched it against the most common mutation of the coronavirus, according to a new study.The product, manufactured by Moderna, a biotechnology company based in Massachusetts, was tested on a modified strain that simulated the D614G mutation of the coronavirusResearch has shown this is present in more than 70 per cent of the confirmed infections around the world, and in close to 100 per cent in…

Read the original article at South China Morning Post